Physician profile
Doris Yang
NPI 1467809210
$1,823.14
in general payments reported to CMS, 2019-2025
15 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $158 · 2021: $121 · 2022: $214 · 2023: $277 · 2024: $412 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $600.48 | 2019-2025 | Lifevest |
| Pfizer INC. | $313.65 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $298.09 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $120.20 | 2020-2024 | Xarelto |
| Abbvie INC. | $105.39 | 2021-2025 | Dalvance |
| Cvrx, INC. | $81.17 | 2022-2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.18 | 2019-2022 | |
| Abbott Laboratories | $46.04 | 2024-2025 | Cardiomems |
| Silk Road Medical, INC. | $45.12 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Astrazeneca Pharmaceuticals Lp | $39.23 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $38.57 | 2019-2024 | Eliquis |
| Allergan, INC. | $30.31 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $16.52 | 2024 | Assure Wcd |
| Smith+Nephew, INC. | $15.97 | 2025 | Collagenase Santyl |
| Bard Peripheral Vascular, INC. | $14.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doris Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.